Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 18/20 | 0.73 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.57 |
| ▸ | P4HA1 | P13674 | 1/20 | 0.52 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.52 |
| ▸ | NNMT | P40261 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL185895 | 0.85 | HCAR3 (1.00) | HCAR3HCAR2P4HA1P4HTMNNMT | |
| SCHEMBL30403146 | 0.85 | HCAR3 (1.00) | HCAR3HCAR2P4HA1P4HTMNNMT | |
| Hydrochloric Acid SCHEMBL6474495 | 0.83 | HCAR3 (0.96) | HCAR3HCAR2P4HA1P4HTMNNMT | |
| Hydrochloric Acid SCHEMBL4035906 | 0.83 | HCAR3 (0.96) | HCAR3HCAR2P4HA1P4HTMNNMT | |
| SCHEMBL14167607 | 0.81 | HCAR3 (0.62) | HCAR3HCAR2P4HA1P4HTM | |
| SCHEMBL14341697 | 0.80 | HCAR3 (0.76) | HCAR3HCAR2P4HA1P4HTM | |
| SCHEMBL27874609 | 0.79 | HCAR3 (0.69) | HCAR3HCAR2 | |
| SCHEMBL3566055 | 0.79 | HCAR3 (0.69) | HCAR3HCAR2P4HA1P4HTM | |
| SCHEMBL82675 | 0.78 | HCAR3 (0.68) | HCAR3HCAR2 | |
| SCHEMBL158601 | 0.77 | HCAR3 (0.67) | HCAR3HCAR2P4HA1P4HTM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019183587-A1 | COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS, INC. (US) | 2019-09-26 | — | — | WO | disclosed |
| EP-2295407-B1 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | SOLULINK INC (US) | 2014-11-05 | — | — | EP | disclosed |
| WO-2012069608-A1 | TECHNETIUM-99M COMPLEX AS A TOOL FOR THE IN VIVO DIAGNOSIS OF CANCEROUS TUMOURS | PIERRE FABRE MEDICAMENT (FR) | 2012-05-31 | — | — | WO | disclosed |